These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1176212)

  • 1. A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.
    Steele G; Sjögren HO; Lannerstad O; Stadenberg I
    Int J Cancer; 1975 Oct; 16(4):682-93. PubMed ID: 1176212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro cell-mediated immune reactions of melanoma and colorectal carcinoma patients demonstrated by long-term 51chromium assays.
    Steele G; Sjögren HO; Stadenberg I
    Int J Cancer; 1976 Jan; 17(1):27-39. PubMed ID: 1248900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 51Cr release for detecting cell-mediated cytotoxic responses to solid chemically induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Br J Cancer; 1977 Jun; 35(6):834-43. PubMed ID: 194618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of cell-mediated immunity in B77 tumor bearing rats by 51chromium release assay.
    Kalafut F; Novotná L; Valentová N
    Neoplasma; 1981; 28(6):689-95. PubMed ID: 7339497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonic antigens associated with chemically induced colon carcinomas in rats.
    Steele G; Sjogren HO
    Int J Cancer; 1974 Oct; 14(4):435-44. PubMed ID: 4376522
    [No Abstract]   [Full Text] [Related]  

  • 6. Absorption of blocking activity from human tumor-bearer sera by Staphylococcus aureus, Cowan I.
    Steele G; Ankerst J; Sjögren HO; Vang J; Lannerstad O
    Int J Cancer; 1975 Feb; 15(2):180-9. PubMed ID: 1126756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated and embryonic antigens in soluble fractions of a chemically-induced rat colon carcinoma.
    Steele G; Sjögren HO; Price MR
    Int J Cancer; 1975 Jul; 16(1):33-51. PubMed ID: 1176194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kinetic study of antitumor lymphocyte cytotoxicity in rats bearing progressive or regressive syngeneic colonic tumors].
    Pelletier H; Olsson O; Lagadec P; Reisser D; Jeannin JF
    C R Seances Soc Biol Fil; 1985; 179(5):669-78. PubMed ID: 2938696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonspecific lymphocyte cytotoxicity in patients with malignant melanoma, renal cell carcinoma, and sarcomas, and in nontumor patients.
    Bukowski RM; Barna B; Deodhar SD; Hewlett JS
    Cancer; 1976 Nov; 38(5):1962-7. PubMed ID: 991109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated responses in dogs with spontaneous neoplasms. I. Detection of cell-mediated cytotoxicity by the chromium-51 release assay.
    Betton GR; Gorman NT
    J Natl Cancer Inst; 1978 Oct; 61(4):1085-93. PubMed ID: 279712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface antigens in a rat colon cancer model: correlation with inhibition of tumor growth.
    Steele G; Sjogren HO
    Surgery; 1977 Jul; 82(1):164-9. PubMed ID: 877853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells.
    Holden HT; Oldham RK; Ortaldo JR; Herberman RB
    J Natl Cancer Inst; 1977 Mar; 58(3):611-22. PubMed ID: 839557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. II. Syngeneic colon carcinoma CC531 is efficiently killed by retargeted cytotoxic T lymphocytes in vitro despite limited lysis in 51Cr release assays.
    Beun GD; Gorter A; Nooyen Y; van de Velde CJ; Fleuren GJ
    J Immunol; 1993 Mar; 150(6):2305-15. PubMed ID: 8450213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
    Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
    Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
    Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells.
    Jost LM; Kirkwood JM; Whiteside TL
    J Immunol Methods; 1992 Mar; 147(2):153-65. PubMed ID: 1548398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cyclophosphamide on in vitro correlates of tumor immunity.
    Steele G; Sjögren HO; Ankerst J
    Int J Cancer; 1974 Dec; 14(6):743-52. PubMed ID: 4377004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays.
    Wiltrout RH; Frost P; Cummings GD
    J Natl Cancer Inst; 1978 Jul; 61(1):183-8. PubMed ID: 97392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells.
    Ting CC; Nunn ME; Park JY; Herberman RB
    J Natl Cancer Inst; 1977 Feb; 58(2):331-7. PubMed ID: 833881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An isotope-release assay and terminal-labeling assay for measuring cell-mediated allograft and tumor immunity to small numbers of adherent target cells.
    Tamerius JD; Garrigues HJ; Hellström I; Hellström KE
    J Immunol Methods; 1978; 22(1-2):1-22. PubMed ID: 78950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.